Type of Cancer
Skin and Soft Tissue
A Phase II Randomized, Double Blinded Study of the Peroxisome Proliferator-Activated Receptor Gamma Agonist, Efatutazone vs. Placebo in Patients with Previously Treated, Unresectable Myxoid Liposarcoma
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.